Finding Drugs, Foiling Disease
Partner with Northeastern.
Minimize Risk. Maximize Insights. Multiply Results.
Purposeful Partnering for Customized Solutions
Pathways to Partnership events are panel discussions aimed at cultivating connections between Northeastern research laboratories and R&D professionals. During these events, Northeastern panelists outline research capabilities and field questions thereby stimulating partnering opportunities for customized solutions.
Finding Drugs, Foiling Disease
Powering Northeastern’s drug discovery agenda, panelists represent expertise in:
Cancer therapies | Cardiovascular diseases | Drug tolerance | Regenerative medicine | CNS diseases | Drug delivery | Antibiotics | Computational modeling | Mass spectrometry | Drug addiction
Northeastern has the pharmacological, biochemical, and biophysical knowledge to make the molecules that will become the next generation of drugs.
~ Diomedes Logothetis, Northeastern University
Venture & Project Presenters
Scientific Founder and Chief Scientist, Seropeutics | Professor, Pharmaceutical Sciences
Seropeutics develops efficacious therapies addressing the needs of Fragile X syndrome, the most common monogenetic form of autism, and has identified two promising candidates, SERx – 519 and SERx – 480 (preclinical development stage).
Director, Center for High-rate Nanomanufacturing | Distinguished Professor and Chair, College of Engineering
The Nanoscale Offset Printing System (NanoOps), developed by the Center for High-rate Nanomanufacturing and Milara Inc., represents the ability to print a sweeping array of pharma products of diverse composition with efficient precision.
Founder, Flaskworks | Professor, College of Engineering
Flaskworks develops modular, closed, and disposable systems for the manufacture of dendritic cells and stimulation and expansion of T cells for the rapidly growing immuno-oncology and dendritic cell-based vaccine markets.
Dr. Srinivas Sridhar
Founder, TheraNano | Distinguished Professor, College of Science
TheraNano has a strong pipeline of nanomedicine and medical imaging technologies, including: a platform for sustained delivery of chemotherapeutics; nanoformulations of PARP and other inhibitors for cancer therapy; and, a quantitative MRI method utilizing magnetic nanoparticles to obtain unprecedented vascular images.
Distinguished Professor, College of Science
The Tilly Lab improves women’s reproductive health and overcomes infertility by translating discoveries made through cellular, molecular, genetic, and epigenetic studies of female germ cells. Findings have opened regenerative avenues for overcoming infertility and preventing ovarian failure while also sparking research targeting mitochondria and cellular energy pathways.
Director, Woods Lab | Associate Professor, College of Science
Focusing on female reproduction, the Woods Lab emphasizes new strategies to delay or prevent ovarian failure. Areas of investigation include: the targeted specification of multiple ovarian cell lineages from stem cells; the interaction between ovarian soma and adult ovary germline; the contribution of germline and soma to ovarian failure; and, bioengineering an ‘artificial’ ovary for generating functional eggs from stem cells.